Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.

Autor: Guest EM; Division of Hematology, Oncology, Bone Marrow Transplant, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO. eguest@cmh.edu., Kairalla JA; Department of Biostatistics, University of Florida, Gainesville, FL., Devidas M; St. Jude Children's Research Hospital, Memphis, TN., Hibbitts E; Department of Biostatistics, University of Florida, Gainesville, FL., Carroll AJ; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL., Heerema NA; Department of Pathology, The Ohio State University, Columbus, OH., Kubaney HR; Dell Children's Medical Center of Central Texas, Austin, TX., August MA; Health Informatics and Technology, Children's Mercy Kansas City, Kansas City, MO., Ramesh S; University of Pennsylvania, Philadelphia, PA., Yoo B; Research Informatics, Children's Mercy Kansas City, Kansas City, MO., Farooqi MS; Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO., Pauly MG; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Emory University, Atlanta, GA., Wechsler DS; Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and Emory University, Atlanta, GA., Miles RR; University of Utah, Department of Pathology, Salt Lake City, UT., Reid JM; Mayo Clinic, Rochester, MN., Kihei CD; Saint Mary's Hospital, West Palm Beach, FL., Gore L; Children's Hospital Colorado, Center for Cancer and Blood Disorders, Denver, CO., Raetz EA; New York University Langone Health, New York, NY., Hunger SP; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA., Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, 98105., Brown PA; Bristol Myers Squibb, Princeton, NJ.

Publikováno v: Haematologica [Haematologica] 2024 Jun 13. Date of Electronic Publication: 2024 Jun 13.